OPRX OptimizeRx Corporation Stock Quote

OPRX [NASD]

Healthcare | Health Information Services | USA

Index	-	P/E	-	EPS (ttm)	-0.16	Insider Own	3.40%	Shs Outstand	17.88M	Perf Week	-9.71%
Market Cap	446.01M	Forward P/E	21.70	EPS next Y	1.13	Insider Trans	-9.76%	Shs Float	15.93M	Perf Month	-26.60%
Income	-2.70M	PEG	-	EPS next Q	0.09	Inst Own	86.70%	Short Float	7.23%	Perf Quarter	-38.03%
Sales	63.80M	P/S	6.99	EPS this Y	114.40%	Inst Trans	3.50%	Short Ratio	6.23	Perf Half Y	-64.70%
Book/sh	7.33	P/B	3.35	EPS next Y	54.64%	ROA	-2.00%	Target Price	59.25	Perf Year	-49.13%
Cash/sh	4.90	P/C	5.01	EPS next 5Y	50.00%	ROE	-2.10%	52W Range	21.33 - 99.18	Perf YTD	-60.46%
Dividend	-	P/FCF	148.67	EPS past 5Y	16.40%	ROI	0.30%	52W High	-75.24%	Beta	0.93
Dividend %	-	Quick Ratio	16.40	Sales past 5Y	51.20%	Gross Margin	59.00%	52W Low	15.14%	ATR	2.30
Employees	97	Current Ratio	16.40	Sales Q/Q	22.30%	Oper. Margin	-4.50%	RSI (14)	37.01	Volatility	6.23% 8.50%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-431.50%	Profit Margin	-4.30%	Rel Volume	0.71	Prev Close	25.49
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 04 AMC	Payout	-	Avg Volume	184.84K	Price	24.56
Recom	1.80	SMA20	-7.78%	SMA50	-27.35%	SMA200	-56.55%	Volume	131,859	Change	-3.65%

Oct-18-21

Resumed

B. Riley Securities

Buy

$102

Apr-13-21

Initiated

RBC Capital Mkts

Outperform

$65

Jan-03-19

Initiated

William Blair

Outperform

May-24-22 08:00AM	OptimizeRx to Participate in Upcoming June Conferences GlobeNewswire
May-17-22 10:00AM	OptimizeRxs Mike Rousselle Named One of 2022 PM360 ELITE 100 GlobeNewswire +12.30%
08:30AM	OptimizeRx Authorizes $20 Million Share Repurchase Program GlobeNewswire
May-10-22 11:05AM	Despite shrinking by US$89m in the past week, OptimizeRx (NASDAQ:OPRX) shareholders are still up 953% over 5 years Simply Wall St.
08:00AM	OptimizeRx to Participate in Upcoming May Conferences GlobeNewswire
May-04-22 05:55PM	OptimizeRx Corp. (OPRX) Reports Q1 Loss, Lags Revenue Estimates Zacks
04:01PM	OptimizeRx Reports First Quarter 2022 Financial Results, Revenue Up 22%, Successfully Completes EvinceMed Acquisition GlobeNewswire
Apr-29-22 08:00AM	OptimizeRx Releases First Environmental, Social and Governance (ESG) Report GlobeNewswire
Apr-27-22 03:03PM	Earnings Preview: OptimizeRx Corp. (OPRX) Q1 Earnings Expected to Decline Zacks -7.02%
Apr-21-22 08:00AM	OptimizeRx Sets First Quarter Fiscal 2022 Conference Call for Wednesday, May 4 at 4:30 p.m. ET GlobeNewswire -5.50%
Apr-20-22 05:33PM	UPDATE Surveyed Physicians Say Access Challenges Impact Their Care Plans for up to 33% of Patients GlobeNewswire
Apr-19-22 09:17AM	1 in 3 Surveyed Physicians Say They Would Make a Different Treatment Choice If Medication Access Was Not a Factor GlobeNewswire
Apr-05-22 11:00AM	Financial Times Ranks OptimizeRx Amongst Americas Fastest-Growing Companies for the Third Consecutive Year GlobeNewswire
Mar-29-22 08:00AM	Augmedix Names William Febbo as New Member to its Board of Directors GlobeNewswire
Mar-15-22 08:00AM	OptimizeRx Acquires EvinceMed, a Specialty Drug Prescription Initiation Platform GlobeNewswire
Mar-07-22 08:00AM	OptimizeRx to Participate In-Person at 34th Annual ROTH Conference, March 13-15, 2022 GlobeNewswire
Feb-25-22 08:01AM	OptimizeRx Corporation (OPRX) Q4 2021 Earnings Call Transcript Motley Fool +5.17%
Feb-24-22 05:30PM	OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates Zacks +8.43%
04:01PM	OptimizeRx Reports Fourth Quarter and Full Year 2021 Financial Results, Revenue Increased 42%, Demand from Large Pharma Gains Momentum GlobeNewswire
Feb-22-22 08:00AM	Top 10 Pharma Deploys OptimizeRxs Digital Access Solution to Streamline Patient Therapy Initiation Challenges GlobeNewswire -5.25%
Feb-17-22 03:03PM	OptimizeRx Corp. (OPRX) Reports Next Week: Wall Street Expects Earnings Growth Zacks -8.26%
Feb-15-22 08:00AM	OptimizeRx Announces Preliminary Fourth Quarter 2021 Financial Results, Introduces New Key Performance Indicators and Provides Initial 2022 Guidance GlobeNewswire +13.25%
Feb-10-22 08:00AM	OptimizeRx Sets Fourth Quarter and Full Year 2021 Conference Call for Thursday, February 24 at 4:30 p.m. ET GlobeNewswire
Feb-07-22 08:00AM	OptimizeRx CEO, William Febbo, to Speak at the Bank of America Annual HCIT and Digital Health Conference GlobeNewswire
Feb-04-22 01:38PM	Cannon Global Investment Management, LLC Buys BHP Group, SPDR S&P Regional Banking ETF, ... GuruFocus.com
Feb-01-22 09:38AM	Jackson Creek Investment Advisors LLC Buys ITeos Therapeutics Inc, Extreme Networks Inc, SMART ... GuruFocus.com
08:00AM	OptimizeRxs Mike Rousselle Named to MM+Ms 40 Under 40 List of the Medical Marketing Industrys Brightest Young Stars GlobeNewswire
Jan-31-22 08:00AM	OptimizeRx to Participate in Upcoming February Investor Conferences GlobeNewswire +10.64%
Jan-19-22 07:55AM	3 Under-the-Radar COVID Stocks Motley Fool
Jan-18-22 08:00AM	OptimizeRxs AI-Driven Therapy Initiation and Persistence Platform Wins 2022 BIG Innovation Award GlobeNewswire -5.96%
Jan-03-22 08:00AM	OptimizeRx to Participate in Panel Presentation at LifeSci Partners Corporate Access Event 2022 GlobeNewswire
Dec-29-21 08:00AM	OptimizeRxs Evidence-Based Physician Engagement Solution Named One of the Most Innovative Products of the Year by PM360 GlobeNewswire
Dec-22-21 08:00AM	OptimizeRx CEO Issues Open Letter to Shareholders Detailing the Completion of Internal Management Changes GlobeNewswire
Dec-15-21 02:38PM	OptimizeRx Survey Addresses Treatment Selection, Discontinuation and Switching in Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer an Indication with Limited Patient Population GlobeNewswire
Dec-08-21 08:00AM	OptimizeRx Recognized by Digital Health Awards® Fall 2021 for TelaRep and its COVID-19 Text Message Campaign GlobeNewswire
Nov-23-21 08:00AM	OptimizeRx Ranked Among Fastest-Growing Companies in North America on the 2021 Deloitte Technology Fast 500 GlobeNewswire
Nov-22-21 08:00AM	OptimizeRx to Participate at the Upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference GlobeNewswire
Nov-16-21 08:00AM	OptimizeRx and Reuters Events Team Up with I AM ALS and RESOLVE: The National Infertility Association for Innovate4Outcomes GlobeNewswire
Nov-10-21 06:53AM	2 Small Caps That Are Soaring in 2021 Motley Fool
05:32AM	OPTIMIZERX CORP (OPRX) Q3 2021 Earnings Call Transcript Motley Fool
Nov-09-21 07:25PM	OptimizeRx Corp. (OPRX) Misses Q3 Earnings Estimates Zacks -8.06%
04:05PM	OptimizeRx Reports Third Quarter 2021 Financial Results, Revenue Increased 53% in Continued Scale Up for Accelerated Growth GlobeNewswire
Nov-05-21 08:00AM	Predictive Analytics Solutions Create New Opportunities for Life Sciences to Address Delayed Diagnosis and other Challenges in Multiple Sclerosis Treatment GlobeNewswire
Nov-02-21 03:02PM	OptimizeRx Corp. (OPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Oct-30-21 03:00AM	These 2 Telehealth Companies Should Unite Motley Fool
Oct-27-21 08:00AM	OptimizeRx Sets Third Quarter Fiscal 2021 Conference Call for Tuesday, November 9 at 4:30 p.m. ET GlobeNewswire
Oct-25-21 07:30AM	OptimizeRx to Participate in Fireside Chat at the Credit Suisse 30th Annual Healthcare Conference GlobeNewswire
Oct-21-21 03:22PM	OptimizeRx Stock Scores Healthy Composite Rating Investor's Business Daily +5.21%
Oct-04-21 01:06PM	Calculating The Intrinsic Value Of OptimizeRx Corporation (NASDAQ:OPRX) Simply Wall St.
07:30AM	Could OptimizeRx Solve This Problem in the Pharma Industry? Motley Fool
Oct-03-21 08:30AM	Why Would Doctors Use OptimizeRx? Motley Fool
Oct-02-21 09:00AM	This Healthcare Tech Stock Wants to Cut Out the Middleman Motley Fool
Oct-01-21 04:44AM	51 Biggest Movers From Yesterday Benzinga
Sep-30-21 12:09PM	36 Stocks Moving In Thursday's Mid-Day Session Benzinga +14.13%
07:30AM	OptimizeRx Appoints Seasoned Financial and Operational Executive, Edward Stelmakh as Chief Financial Officer and Chief Operations Officer GlobeNewswire
Sep-29-21 06:39PM	OptimizeRx Set to Join S&P SmallCap 600 PR Newswire
08:00AM	OptimizeRx Survey Demonstrates Value of Digital Solutions in Addressing Unmet Patient and Provider Needs in Diabetes GlobeNewswire
Sep-14-21 08:00AM	OptimizeRx Announces Significant Platform Enhancement to Digitize Pharmaceutical Access Solutions GlobeNewswire
Sep-09-21 07:07PM	Notable Optimizerx Insider Trades $905.02 Thousand In Company Stock Benzinga
Sep-08-21 08:00AM	OptimizeRx Welcomes Andrew DSilva as Senior Vice President of Corporate Finance GlobeNewswire
Sep-07-21 08:00AM	OptimizeRx Recognized as a Finalist in Questexs Fierce Pharma Marketing Awards 2021 GlobeNewswire
Sep-01-21 08:00AM	OptimizeRx to Present at Upcoming September Investor Conferences GlobeNewswire
Aug-20-21 10:19AM	Can Mixed Fundamentals Have A Negative Impact on OptimizeRx Corporation (NASDAQ:OPRX) Current Share Price Momentum? Simply Wall St.
Aug-17-21 08:00AM	OptimizeRx and Demandbase Form Exclusive Account-Based-Experience (ABX) Partnership Delivering Industrys Most Powerful ABX Solution for Life Sciences GlobeNewswire
Aug-04-21 06:35PM	OptimizeRx Corp. (OPRX) Surpasses Q2 Earnings and Revenue Estimates Zacks
04:01PM	OptimizeRx Reports Second Quarter 2021 Financial Results, Revenue Up 55% as Leading Pharma Brands Aggressively Seek Improved ROI Through Technology Adoption GlobeNewswire
Jul-28-21 03:03PM	OptimizeRx Corp. (OPRX) Reports Next Week: Wall Street Expects Earnings Growth Zacks +5.20%
Jul-27-21 08:00AM	OptimizeRx Sets Second Quarter Fiscal 2021 Conference Call for Wednesday, August 4 at 4:30 p.m. ET GlobeNewswire
Jul-14-21 08:00AM	OptimizeRx Announces Agreement with a Top Pharmaceutical Manufacturer to Use its Evidence-Based Physician Engagement to Solve Lapse in Medical Coverage Barrier for Patients GlobeNewswire
Jul-08-21 06:39AM	2 Top Small-Cap Stocks to Buy in July Motley Fool
Jul-05-21 07:06AM	Returns On Capital Are Showing Encouraging Signs At OptimizeRx (NASDAQ:OPRX) Simply Wall St.
Jul-01-21 12:00PM	OptimizeRx Corp. (OPRX) Upgraded to Strong Buy: Here's Why Zacks
Jun-15-21 08:00AM	OptimizeRx Aligned With Pharma Across Fast Growing Specialty Therapeutic Areas GlobeNewswire
Jun-01-21 08:00AM	OptimizeRx Named to LD Micros Hall of Fame As One of the Top 50 Performing Companies GlobeNewswire
May-25-21 08:00AM	OptimizeRx to Participate in the William Blair 41st Annual Growth Stock Conference GlobeNewswire
May-20-21 06:07AM	Companies Like OptimizeRx (NASDAQ:OPRX) Can Afford To Invest In Growth Simply Wall St.
May-11-21 08:00AM	OptimizeRx to Present at RBC Capital Markets Global Virtual Healthcare Conference on May 19, 2021 GlobeNewswire
May-07-21 01:31AM	OPTIMIZERX CORP (OPRX) Q1 2021 Earnings Call Transcript Motley Fool +9.24%
May-06-21 06:25PM	OptimizeRx Corp. (OPRX) Q1 Earnings and Revenues Beat Estimates Zacks
04:01PM	OptimizeRx Reports First Quarter 2021 Financial Results, Revenue Up 48% on Rising Enterprise Adoption of Digital Health GlobeNewswire
02:45PM	OptimizeRx Corp. to Host Earnings Call ACCESSWIRE
Apr-29-21 05:05PM	OptimizeRx Corp. (OPRX) Earnings Expected to Grow: Should You Buy? Zacks
Apr-28-21 08:00AM	OptimizeRx Sets First Quarter 2021 Conference Call for Thursday, May 6, 2021 at 4:30 p.m. ET GlobeNewswire
Apr-27-21 07:51AM	OptimizeRx Expands Omni-channel Platform Reach at Point-Of-Care GlobeNewswire
Apr-23-21 07:01AM	These Smaller Tech Companies Have Postpandemic Promise, Says Jacob Funds Manager Barrons.com
12:05AM	Which tech stocks can build on pandemic gains? Fund manager Ryan Jacob offers these two names. MarketWatch
Apr-13-21 07:51AM	OptimizeRx Named to Financial Times The Americas Fastest-Growing Companies List for the Second Consecutive Year GlobeNewswire
Apr-05-21 10:41AM	Calculating The Intrinsic Value Of OptimizeRx Corporation (NASDAQ:OPRX) Simply Wall St. -8.89%
Apr-04-21 06:15AM	2 Biotech Stocks That Could Be Millionaire Makers Motley Fool
Mar-22-21 09:25AM	OptimizeRX Will Continue To Thrive Post-Pandemic TipRanks +7.64%
Mar-17-21 08:52AM	Company News for Mar 17, 2021 Zacks
Mar-16-21 12:25PM	Return On Capital Employed Overview: OptimizeRx Benzinga +15.09%
07:30AM	OptimizeRx Recurring Revenue Grows as it Secures 19 New Enterprise-Level Engagements in Q1 2021 GlobeNewswire
Mar-03-21 07:31AM	OptimizeRx to Participate at the 33rd Annual Virtual ROTH Conference on March 15-17, 2021 GlobeNewswire -6.32%
Mar-02-21 05:22AM	OptimizeRx Corp. (OPRX) Soars 12%: Is Further Upside Left in the Stock? Zacks
Feb-26-21 06:00PM	1 Under-the-Radar Stock For Healthcare Investors to Buy Now Motley Fool -5.05%
Feb-25-21 06:00AM	3 Top Healthcare Stocks to Buy in 2021 Motley Fool
04:31AM	OPTIMIZERX CORP (OPRX) Q4 2020 Earnings Call Transcript Motley Fool
Feb-24-21 04:01PM	OptimizeRx Reports Q4 2020 Revenue Up 123% to Record $16.4 Million, Driving Net Income of $1.4 Million or $0.08 Per Share GlobeNewswire
02:30PM	OptimizeRx Corp. to Host Earnings Call ACCESSWIRE

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
FEBBO WILLIAM J	CHIEF EXECUTIVE OFFICER	Feb 18	Sale	43.73	16,666	728,837	445,672	Feb 23 04:45 PM
FEBBO WILLIAM J	CHIEF EXECUTIVE OFFICER	Jan 18	Sale	47.27	16,666	787,772	462,338	Jan 20 04:45 PM
Silvestro Stephen L	CHIEF COMMERCIAL OFFICER	Dec 17	Option Exercise	7.51	13,241	99,440	13,241	Dec 21 04:45 PM
Silvestro Stephen L	CHIEF COMMERCIAL OFFICER	Dec 17	Sale	54.87	13,241	726,534	0	Dec 21 04:45 PM
FEBBO WILLIAM J	CHIEF EXECUTIVE OFFICER	Dec 15	Sale	54.55	16,666	909,130	469,377	Dec 17 04:45 PM
Paramore Miriam J	PRESIDENT AND CSO	Dec 02	Option Exercise	7.51	3,558	26,721	74,607	Dec 03 04:45 PM
Paramore Miriam J	PRESIDENT AND CSO	Dec 02	Sale	61.48	3,558	218,746	71,049	Dec 03 04:45 PM
Silvestro Stephen L	CHIEF COMMERCIAL OFFICER	Nov 17	Option Exercise	7.51	13,241	99,440	13,241	Nov 19 04:45 PM
Silvestro Stephen L	CHIEF COMMERCIAL OFFICER	Nov 17	Sale	73.98	13,241	979,569	0	Nov 19 04:45 PM
FEBBO WILLIAM J	CHIEF EXECUTIVE OFFICER	Nov 15	Sale	82.18	16,666	1,369,612	486,043	Nov 17 04:45 PM
Spangler Patrick D	Director	Nov 11	Sale	84.38	6,252	527,544	16,083	Nov 15 04:45 PM
Paramore Miriam J	PRES. & CHIEF STRATEGY OFFICER	Nov 02	Option Exercise	7.51	15,000	112,650	89,607	Nov 03 04:45 PM
Paramore Miriam J	PRES. & CHIEF STRATEGY OFFICER	Nov 02	Sale	95.45	15,000	1,431,750	74,607	Nov 03 04:45 PM
Silvestro Stephen L	CHIEF COMMERCIAL OFFICER	Oct 18	Option Exercise	7.51	13,241	99,440	13,241	Oct 19 04:45 PM
Silvestro Stephen L	CHIEF COMMERCIAL OFFICER	Oct 18	Sale	85.38	13,241	1,130,517	0	Oct 19 04:45 PM
FEBBO WILLIAM J	CHIEF EXECUTIVE OFFICER	Oct 15	Sale	84.20	16,666	1,403,277	502,709	Oct 19 04:45 PM
BAKER DOUGLAS P	CHIEF FINANCIAL OFFICER	Oct 05	Option Exercise	7.51	10,000	75,100	44,796	Oct 05 04:45 PM
BAKER DOUGLAS P	CHIEF FINANCIAL OFFICER	Oct 05	Sale	82.88	14,000	1,160,380	34,796	Oct 05 04:45 PM
Paramore Miriam J	PRESIDENT AND CSO	Oct 04	Option Exercise	7.51	15,000	112,650	89,607	Oct 05 04:45 PM
Paramore Miriam J	PRESIDENT AND CSO	Oct 04	Sale	84.67	15,000	1,270,050	74,607	Oct 05 04:45 PM
BAKER DOUGLAS P	CHIEF FINANCIAL OFFICER	Sep 28	Sale	74.66	2,000	149,320	38,796	Sep 29 04:45 PM
BAKER DOUGLAS P	CHIEF FINANCIAL OFFICER	Sep 21	Sale	70.59	4,000	282,360	40,796	Sep 22 04:45 PM
Silvestro Stephen L	CCO	Sep 17	Option Exercise	7.51	13,242	99,447	13,242	Sep 21 04:45 PM
Silvestro Stephen L	CCO	Sep 17	Sale	69.79	13,242	924,159	0	Sep 21 04:45 PM
FEBBO WILLIAM J	CHIEF EXECUTIVE OFFICER	Sep 15	Sale	65.74	16,666	1,095,623	519,375	Sep 17 04:45 PM
BAKER DOUGLAS P	CHIEF FINANCIAL OFFICER	Sep 14	Sale	65.57	3,768	247,068	44,796	Sep 15 04:45 PM
BAKER DOUGLAS P	CHIEF FINANCIAL OFFICER	Sep 08	Option Exercise	7.51	10,000	75,100	58,564	Sep 09 04:46 PM
BAKER DOUGLAS P	CHIEF FINANCIAL OFFICER	Sep 08	Sale	67.25	10,000	672,500	48,564	Sep 09 04:46 PM
BAKER DOUGLAS P	CHIEF FINANCIAL OFFICER	Sep 07	Sale	70.53	2,232	157,423	48,564	Sep 09 04:46 PM
Paramore Miriam J	PRESIDENT AND CSO	Sep 02	Option Exercise	7.51	15,000	112,650	89,607	Sep 03 04:45 PM
Paramore Miriam J	PRESIDENT AND CSO	Sep 02	Sale	68.39	15,000	1,025,850	74,607	Sep 03 04:45 PM
BAKER DOUGLAS P	CHIEF FINANCIAL OFFICER	Aug 31	Sale	66.62	4,000	266,480	50,796	Sep 02 04:46 PM
BAKER DOUGLAS P	CHIEF FINANCIAL OFFICER	Aug 24	Sale	61.50	4,000	246,000	54,796	Aug 24 04:45 PM
BAKER DOUGLAS P	CHIEF FINANCIAL OFFICER	Aug 20	Sale	58.45	5,000	292,250	58,796	Aug 24 04:45 PM
Silvestro Stephen L	CHIEF COMMERCIAL OFFICER	Aug 17	Option Exercise	7.51	13,242	99,447	13,242	Aug 19 04:45 PM
Silvestro Stephen L	CHIEF COMMERCIAL OFFICER	Aug 17	Sale	58.41	13,242	773,465	0	Aug 19 04:45 PM
BAKER DOUGLAS P	CHIEF FINANCIAL OFFICER	Aug 17	Sale	58.46	4,000	233,840	63,796	Aug 17 04:46 PM
FEBBO WILLIAM J	CHIEF EXECUTIVE OFFICER	Aug 16	Sale	60.46	16,666	1,007,626	544,641	Aug 17 04:46 PM
BAKER DOUGLAS P	CHIEF FINANCIAL OFFICER	Aug 13	Sale	63.27	5,000	316,350	67,796	Aug 17 04:46 PM
BAKER DOUGLAS P	CHIEF FINANCIAL OFFICER	Aug 10	Sale	64.50	2,000	129,000	72,796	Aug 10 04:45 PM
BAKER DOUGLAS P	CHIEF FINANCIAL OFFICER	Aug 09	Option Exercise	7.51	10,000	75,100	74,796	Aug 10 04:45 PM
BAKER DOUGLAS P	CHIEF FINANCIAL OFFICER	Aug 09	Sale	64.31	10,000	643,100	64,796	Aug 10 04:45 PM
BAKER DOUGLAS P	CHIEF FINANCIAL OFFICER	Aug 03	Sale	54.93	2,000	109,860	74,796	Aug 03 04:45 PM
Paramore Miriam J	PRESIDENT AND CSO	Aug 02	Option Exercise	7.51	15,000	112,650	89,607	Aug 03 04:45 PM
Paramore Miriam J	PRESIDENT AND CSO	Aug 02	Sale	55.76	15,000	836,400	74,607	Aug 03 04:45 PM
BAKER DOUGLAS P	CHIEF FINANCIAL OFFICER	Jul 27	Sale	52.58	3,000	157,740	76,796	Jul 28 04:45 PM
Silvestro Stephen L	CHIEF COMMERCIAL OFFICER	Jul 20	Option Exercise	7.51	13,242	99,447	13,242	Jul 21 04:45 PM
Silvestro Stephen L	CHIEF COMMERCIAL OFFICER	Jul 20	Sale	50.34	13,242	666,602	0	Jul 21 04:45 PM
BAKER DOUGLAS P	CHIEF FINANCIAL OFFICER	Jul 20	Sale	50.90	3,000	152,700	79,796	Jul 21 04:45 PM
BAKER DOUGLAS P	CHIEF FINANCIAL OFFICER	Jul 08	Option Exercise	2.46	13,435	33,050	82,796	Jul 09 04:45 PM
BAKER DOUGLAS P	CHIEF FINANCIAL OFFICER	Jul 08	Sale	56.05	13,435	753,032	69,361	Jul 09 04:45 PM
BAKER DOUGLAS P	CHIEF FINANCIAL OFFICER	Jun 28	Sale	63.00	3,421	215,523	82,796	Jun 30 04:45 PM
BAKER DOUGLAS P	CHIEF FINANCIAL OFFICER	Jun 24	Sale	60.00	4,000	240,000	86,217	Jun 25 04:45 PM
Silvestro Stephen L	CHIEF COMMERCIAL OFFICER	Jun 17	Option Exercise	7.51	13,242	99,447	13,242	Jun 21 04:15 PM
Silvestro Stephen L	CHIEF COMMERCIAL OFFICER	Jun 17	Sale	53.44	13,242	707,652	0	Jun 21 04:15 PM
BAKER DOUGLAS P	CHIEF FINANCIAL OFFICER	Jun 07	Option Exercise	2.46	14,500	35,670	90,217	Jun 08 04:46 PM
BAKER DOUGLAS P	CHIEF FINANCIAL OFFICER	Jun 07	Sale	52.62	14,500	762,990	75,717	Jun 08 04:46 PM
Paramore Miriam J	PRESIDENT	Jun 04	Sale	51.30	1,667	85,517	7,412	Jun 08 04:45 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience